AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Polaryx Therapeutics, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG01ZPFWWC1
1.85▼ 0.09 (-4.64%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
1.94
Day's Range
1.84 – 1.90
52-Week Range
1.83 – 49.50
Volume
42.8K
Avg Volume
30.1K
Share Statistics
Shares Outstanding
Employees
—
Exchange
XNAS
Listed
2026-02-02
Share count as of July 31, 2026

Polaryx Therapeutics, Inc. Common Stock (PLYX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Polaryx Therapeutics, Inc. Common Stock (PLYX)
What is Polaryx Therapeutics, Inc. Common Stock's Market Cap?
Polaryx Therapeutics, Inc. Common Stock's Market Cap is $92.2M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PLYXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Jun 30, 2025Mar 31, 2025
Operating expenses:
Research and development expenses
General and administrative expenses
Total operating expenses
Operating loss
Other expense – direct listing offering costs
Net loss and comprehensive loss
Net loss per share – basic
Net loss per share – diluted